Soleus Capital Management, L.P.
Position in UTHR — UNITED THERAPEUTICS Corp
CIK 1802630
GREENWICH, CT
Position in UTHR
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$122,229,804
+$11,231,657 QoQ
Shares Held
225,587
+20.5% QoQ
Ownership
0.526%
of shares outstanding
% of Portfolio
4.21%
of 13F equity value
Holder Rank
#41
of 870 holders
Holding Since
Sep 2021
20 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in UTHR Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Soleus Capital Management, L.P. holds $361,941,334 across 8 Drug Manufacturers - Specialty & Generic names. UTHR ranks #1 (33.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | UTHR |
UNITED THERAPEUTICS Corp
This page
|
225,587 | $122,229,804 | |
| 2 | ANIP |
Ani Pharmaceuticals Inc
|
867,760 | $71,833,172 | |
| 3 | ALKS |
Alkermes plc.
|
1,029,252 | $53,932,804 | |
| 4 | INDV |
Indivior Pharmaceuticals, Inc.
|
1,064,000 | $43,655,920 | |
| 5 | ORGO |
Organogenesis Holdings Inc.
|
10,140,951 | $24,642,510 | |
| 6 | SUPN |
Supernus Pharmaceuticals, Inc.
|
520,000 | $24,185,200 | |
| 7 | KNSA |
Kiniksa Pharmaceuticals International, plc
|
246,353 | $15,754,274 | |
| 8 | EOLS |
Evolus, Inc.
|
822,428 | $5,707,650 |
All Filings in UTHR
Export CSV
20 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $122,229,804 | 225,587 | Shares | Sole | 2026-08-11 | |
| 2026-03-31 | $110,998,147 | 187,187 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $29,235,000 | 60,000 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $62,881,500 | 150,000 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $60,284,305 | 209,794 | Shares | Sole | 2025-08-15 | |
| 2025-03-31 | $47,903,308 | 155,394 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $38,598,578 | 109,394 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $36,513,714 | 101,894 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $45,074,506 | 141,499 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $59,669,540 | 259,749 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $54,851,340 | 249,449 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $64,861,958 | 287,165 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $53,583,751 | 242,735 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $30,511,190 | 136,235 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $35,670,048 | 128,268 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $49,174,777 | 234,859 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $69,641,281 | 295,541 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $54,872,548 | 305,850 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $35,501,944 | 164,300 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $18,790,244 | 101,800 | Shares | Sole | 2021-11-15 | |
| No filing history on record for this holder in this stock. | ||||||